Pralsetinib in Patients with Advanced/Metastatic Rearranged During Transfection (RET)-Altered Thyroid Cancer: Updated Efficacy and Safety Data from the ARROW Study

Vivek Subbiah, Mimi I. Hu, Aaron S. Mansfield, Matthew H. Taylor, Martin Schuler, Viola W. Zhu, Julien Hadoux, Giuseppe Curigliano, Lori Wirth, Justin F. Gainor, Guzman Alonso, Douglas Adkins, Yann Godbert, Myung Ju Ahn, Philippe A. Cassier, Byoung Chul Cho, Chia Chi Lin, Alena Zalutskaya, Teresa Barata, Peter TraskAstrid Scalori, Walter Bordogna, Sebastian Heinzmann, Marcia S. Brose

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Pralsetinib in Patients with Advanced/Metastatic Rearranged During Transfection (RET)-Altered Thyroid Cancer: Updated Efficacy and Safety Data from the ARROW Study'. Together they form a unique fingerprint.

Medicine & Life Sciences